AbbVie | ABBV - Zysk Brutto

Cena Akcji
204.14
Dzienna Zmiana
6.45 3.26%
Miesięcznie
-4.21%
Rocznie
4.63%
Q2 Prognozy TE
194.46




Zysk Brutto Zmiana Data
AbbVie USD 2.67B 1.71B 2025-12
Abbott USD 2.39B 27M 2026-03
ALKERMES USD 100.74M 4.1M 2025-09
Amgen USD 3.92B 2.35B 2025-09
AstraZeneca USD 2.63B 615M 2025-12
Biogen USD -56M 613.3M 2025-12
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Coherus Biosciences USD -46.35M 90.86M 2025-12
Eisai JPY 22B 7.47B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.1B 224M 2025-09
Merck USD 6.74B 22M 2025-09
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
Novartis USD 4.64B 445M 2025-12
Pacira USD 9.52M 11.45M 2025-09
Perrigo USD 22.4M 19.2M 2025-09
Pfizer USD 3.33B 290M 2025-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Zoetis USD 887M 15M 2025-09